Actual Medicinal Product (AMP) - Rybelsus 3mg tablets (Novo Nordisk Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Rybelsus 3mg tablets | Start Date 03-08-2020 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 38731811000001101 | 03-08-2020 |
Parent Products
-
VTMSemaglutide
-
VMPSemaglutide 3mg tablets
-
AMP(Current) Rybelsus 3mg tablets (Novo Nor... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 30 tablet | 7848 |